Trials / Terminated
TerminatedNCT01016340
Efficacy and Safety of MCS-5 in Treating Male Oligoasthenospermia
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of MCS-5 in Treating Male Oligoasthenospermia (MCS_MOS)
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- Health Ever Bio-Tech Co., Ltd. · Industry
- Sex
- Male
- Age
- 20 Years
- Healthy volunteers
- Accepted
Summary
This is a phase II randomized, double-blind, placebo-controlled study where eligible subfertile male subjects (age 20 years).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MCS | MCS-5 Softgel 5 mg |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2012-12-01
- Completion
- 2013-06-01
- First posted
- 2009-11-19
- Last updated
- 2023-12-21
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT01016340. Inclusion in this directory is not an endorsement.